美国心脏协会心脏性冲击注册:设计和实施
David A Morrow1, Mariell Jessup2, William T Abraham3
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA (D.A.M.).
Circulation. Cardiovascular quality and outcomes
|June 18, 2024
概括
美国心脏协会 (AHA) 启动了一个注册表,收集有关心脏性休克患者的数据. 这个倡议旨在改善对这种严重心脏病的理解和管理.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心脏性休克是心脏病的严重并发症,死亡率高.
- 对于更好地了解和管理心脏性休克,存在着重大未满足的需求.
- 美国心脏协会已经启动了质量改进注册,以应对这些挑战.
研究的目的:
- 为美国各地心脏性休克患者建立一个全面的注册表.
- 了解临床表型,管理模式和结果.
- 为未来的研究创建一个研究基础设施,并改善患者护理.
主要方法:
- 电子案例记录表格的合作设计与震惊学术研究联盟的定义保持一致.
- 连续住院患有心脏性休克的患者的注册,无论病因或严重程度如何.
- 收集关于诊断,治疗,监测,护理过程,并发症和生存的患者级数据.
主要成果:
- 该登记处于2022年3月31日开始收集临床记录.
- 目前,有100个中心参与该注册.
- 收集的数据将使患者管理和结果的评估成为可能.
结论:
- 该注册表为医学和研究界提供了一个有价值的资源,包含一致的数据.
- 它旨在通过共享学习加速科学进步.
- 最终的目标是改善心脏性休克患者的护理质量和治疗结果.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


